Probiotics in hospitalized adult patients: a systematic review of economic evaluations
Open Access
- 12 November 2019
- journal article
- review article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 67 (2) , 247-261
Abstract
Probiotics may prevent healthcare-associated infections, such as ventilator-associated pneumonia, Clostridioides difficile-associated diarrhea, and other adverse outcomes. Despite their potential benefits, there are no summative data examining the cost-effectiveness of probiotics in hospitalized patients. This systematic review summarized studies evaluating the economic impact of using probiotics in hospitalized adult patients.Keywords
This publication has 46 references indexed in Scilit:
- Microbial Translocation Across the GI TractAnnual Review of Immunology, 2012
- How evidence based is English public health policy?BMJ, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Clinical Risk Factors for Severe Clostridium difficile –associated DiseaseEmerging Infectious Diseases, 2009
- Rising Economic Impact of Clostridium difficile-Associated Disease in Adult Hospitalized Patient PopulationInfection Control & Hospital Epidemiology, 2008
- Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel diseaseGut, 2007
- Preference-Based EQ-5D Index Scores for Chronic Conditions in the United StatesMedical Decision Making, 2006
- Relationship between drug company funding and outcomes of clinical psychiatric researchPsychological Medicine, 2006
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Clostridium difficile—A common and costly colitisDiseases of the Colon & Rectum, 1991